Aanwezigheid of voorgeschiedenis van maligne aandoeningen, met uitzondering van primair basaalcelcarcinoom, carcinoma in situ van de cervix uteri en enkele primaire tumoren van het centrale zenuwstelsel die aan de hand van de wetenschappelijke kennis moeten worden beoordeeld.

https://eur-lex.europa.eu/lega (...) (...) [HTML] [2006-02-07]

Presence, or previous history, of malignant disease, except for primary basal cell carcinoma, carcinoma in situ of the uterine cervix, and some primary tumours of the central nervous system that have to be evaluated according to scientific evidence.

https://eur-lex.europa.eu/lega (...) (...) [HTML] [2006-02-07]

https://eur-lex.europa.eu/lega (...) [HTML] [2006-02-07]

http://eur-lex.europa.eu/legal (...) (...) [HTML] [2006-02-07]

http://eur-lex.europa.eu/legal (...) [HTML] [2006-02-07]

3. aanwezigheid of voorgeschiedenis van maligne aandoeningen, met uitzondering van primair basaalcelcarcinoom, carcinoma in situ van de cervix uteri en enkele primaire tumoren van het centrale zenuwstelsel die aan de hand van het huidige consensusdocument van de Raad van Europa, "Standardisation of organ donor screening to prevent transmission of neoplastic diseases" zijn beoordeeld.

http://www.europarl.europa.eu/ (...) (...) [HTML] [2003-11-11]

3. Presence or previous history of malignant disease, except for primary basal cell carcinoma, carcinoma in situ of the uterine cervix, and some primary tumours of the central nervous system that have to be evaluated according to the current consensus document of the Council of Europe ‘Standardisation of organ donor screening to prevent transmission of neoplasic diseases’.

http://www.europarl.europa.eu/ (...) (...) [HTML] [2003-11-11]

http://www.europarl.europa.eu/ (...) [HTML] [2003-11-11]

3. Aanwezigheid of voorgeschiedenis van maligne aandoeningen, met uitzondering van primair basaalcelcarcinoom, carcinoma in situ van de cervix uteri en enkele primaire tumoren van het centrale zenuwstelsel die aan de hand van het huidige consensusdocument van de Raad van Europa, "Standardisation of organ donor screening to prevent transmission of neoplastic diseases" zijn beoordeeld.

http://www.europarl.europa.eu/ (...) (...) [HTML] [2003-04-09]

3. Presence or previous history of malignant disease, except for primary basal cell carcinoma, carcinoma in situ of the uterine cervix, and some primary tumours of the central nervous system that have to be evaluated according to the current consensus document of the Council of Europe "Standardisation of organ donor screening to prevent transmission of neoplasic diseases".

http://www.europarl.europa.eu/ (...) (...) [HTML] [2003-04-09]

http://www.europarl.europa.eu/ (...) [HTML] [2003-04-09]

D'autres ont cherché : lobulair 'carcinoma in situ' lobulair carcinoma in situ voorgeschiedenis met lobulair carcinoma in situ

datacenter (28): www.wordscope.be (v4.0.br)

'voorgeschiedenis met lobulair carcinoma in situ' ->

Date index: 2023-02-05